Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2001
12/20/2001CA2411366A1 Process for the preparation of 1,2,4-triazolin-5-one derivatives
12/19/2001EP1164134A1 Benzimidazole compounds and their use as modulators of the GABA A receptor complex
12/19/2001EP1163240A1 Tricyclic benzoylpyrazole derivatives used as a herbicide
12/19/2001EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001EP1163237A1 Amide derivatives
12/19/2001EP1163229A1 2,4-diamino-1,3,5-triazines, method for producing them and their use as herbicides and plant growth regulators
12/19/2001EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
12/19/2001EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists
12/19/2001EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001EP0847391B1 Aromatic compounds and pharmaceutical compositions containing them
12/19/2001CN1327444A Alpha 1 beta-adrenergic receptor antagonists
12/19/2001CN1076351C Benzene derivatives substituted by heterocycles and herbicides
12/19/2001CN1076349C Desoxycyclodepsipeptides and their use for combatting endoparasites
12/18/2001USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics
12/18/2001US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
12/18/2001US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors
12/18/2001US6331545 Heterocycyclic piperidines as modulators of chemokine receptor activity
12/18/2001US6331541 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/18/2001US6331537 Treating neurological disorders in animals
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/13/2001WO2001094342A1 Novel oxazolidinone derivatives and a process for the preparation thereof
12/13/2001WO2001094341A1 Quinazoline derivatives for the treatment of tumours
12/13/2001WO2001094340A1 Heterocyclic hydrazones for use as anti-cancer agents
12/13/2001WO2001094339A1 Substituted pyridine herbicides
12/13/2001WO2001094310A1 Methods for making bis-heterocyclic alkaloids
12/13/2001WO2001093682A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/13/2001WO2001044200A3 Selective neurokinin antagonists
12/13/2001US20010051730 Glycoprotein antagonist, inhibitor of blood platelet aggregation and fibrinogen binding
12/13/2001US20010051722 Aminoaryl Oxazolidinone N-oxides
12/13/2001US20010051637 Indole derivatives as prodrugs of 5-HT1-like receptor agonists
12/13/2001US20010051630 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses
12/13/2001US20010051619 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia
12/13/2001CA2411859A1 Novel oxazolidinone derivatives and a process for the preparation thereof
12/13/2001CA2409877A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/12/2001EP1162201A2 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
12/12/2001EP1162199A1 1,3,4-oxadiazole derivatives and process for producing the same
12/12/2001EP1162196A1 Fused-ring compounds and use thereof as drugs
12/12/2001EP1161430A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
12/12/2001EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001EP1161233A2 Lxr modulators
12/12/2001EP0968175B1 Spiro compounds and the use thereof
12/12/2001EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001EP0778827B1 Process for producing a beta-amino alcohol
12/12/2001EP0748319B1 Process for making an epoxide
12/12/2001EP0675924B1 Cyclic-substituted unsymmetrical cyanine dyes
12/12/2001CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001CN1325849A 2-(thio)-4,5-imidazoline trione compounds with herbiciding activity
12/12/2001CN1325848A Herbicidal 3-aryl-1,2,4-triazole derivative
12/11/2001US6329527 Acylating substitutedaryl hydrazine, forming dipolar compound, contacting dipolarophile and subjecting to oxidation, removing protecting group
12/11/2001US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
12/11/2001US6329415 Aromatic heterocyclic compounds as antiinflammatory agents
12/11/2001US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001US6329393 Crystalline pharmaceutically acceptable salts of an oxazolidinone derivative
12/11/2001US6329389 Amine compounds, their production and use
12/11/2001US6329371 α-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
12/11/2001US6329370 Cardiovascular disorders and tumor necrosis factor (hereinafter tnf.sub..alpha.), a cytokine with pro-inflammatory activity
12/11/2001US6329369 Methods of treating pain and other conditions
12/11/2001CA2226292C Substituted benzolactam compounds as substance p antagonists
12/06/2001WO2001092991A2 Design of polyketide synthase genes
12/06/2001WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001WO2001092233A1 3-substituted isoquinolin-1-yl derivatives
12/06/2001WO2001092227A1 Chemical compounds
12/06/2001WO2001046178A3 Substituierte bisindolymaleimide
12/06/2001US20010049445 Process for the preparation of thiazolidinedione derivatives
12/06/2001US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/06/2001US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/06/2001DE10027025A1 Clycinamide Clycinamide
12/06/2001CA2410640A1 3-substituted isoquinolin-1-yl derivatives
12/06/2001CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/05/2001EP1160331A1 Enzymatic oxidations
12/05/2001EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists
12/05/2001EP1160247A1 6,5-Fused aromatic ring systems having enhanced phosphodiesterae IV inhibitory activity
12/05/2001EP1160244A1 Isoxazole derivatives and their use as herbicides
12/05/2001EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s
12/05/2001EP1158986A1 Protease inhibitors
12/05/2001EP1158980A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/05/2001EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex
12/05/2001EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001EP0719261B1 Substituted isoxazolines, process for producing them, agents containing them and their use as safeners
12/05/2001EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
12/05/2001CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands
12/05/2001CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001CN1325267A Fused-benzene derivatives useful as herbicides
12/05/2001CN1075812C Prodrugs of morpholine tachykinin receptor antagonists
12/04/2001US6326492 Heterocyclic protease inhibitors
12/04/2001US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
12/04/2001US6326382 Cholinesterase inhibitors; useful in enhancing memory in patients suffering from dementia and alzheimer's disease
12/04/2001US6326380 Thrombin receptor antagonists
12/04/2001US6326333 Herbicides
11/2001
11/30/2001CA2349057A1 Enzymatic oxidations
11/30/2001CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists